We undertake Systems Pharmacology approaches to personalize multi-agent anticancer pharamcotherapies integrating individual patient data into treatment decision. Such mathematical models are designed though a multi-scale pipeline integrating experimental data from cell culture and animal experiments, together with clincial results from investigations in individual patients of cohorts of patients.